Design and implementation of integrative teaching of traditional Chinese medicine and western medicine in Medical Immunology
Author:
  • Article
  • | |
  • Metrics
  • |
  • Reference [26]
  • | | | |
  • Comments
    Abstract:

    Traditional Chinese medicine (TCM) has played an important role in the prevention and treatment of COVID-19 and formed complementary advantages with western medicine. Integrating with western medicine promotes the innovation and development of TCM and innovates the mode of TCM talent cultivation. We explored the design and performance of integrative teaching (integrating TCM technology in the prevention and treatment of COVID-19) of TCM and western medicine in Medical Immunology. The research subjects included one class of 2019-enrolled students majoring in TCM at Baotou Medical College. We integrated the textbook content of Medical Immunology with the content in the diagnosis and treatment protocol of COVID-19 and related research results to reorganize the teaching content. Various classroom teaching designs were integrated before, during, and after class to reconstruct classroom teaching. The teaching performance was evaluated based on the scores of classroom group report, after-school group task, and Rain Classroom test, and the students were investigated for course satisfaction degree at the end of the course. The students' average score of classroom teaching was 84.507±4.391 and the five indicators of satisfaction degree exceeded 95%, which indicated that the integrative teaching mode of TCM and western medicine in Medical Immunology can enable students to master basic medical knowledge and deeply understand the internal relationship between TCM and western medicine. Moreover, it plays a role of innovating the cultivation mode of TCM talents. Our study provides a reference for the integrative teaching of TCM and western medicine for other medical majors and promotes the development of integrative teaching of TCM and western medicine.

    Reference
    [1] 李佳川, 李思颖, 顾健, 程雪瑶. 基于“治未病”理论中医药预防新型冠状病毒肺炎的回顾与思考[J]. 中药材, 2021, 44(4): 1021-1030 Li JC, Li SY, Gu J, Cheng XY. Review and reflection on the prevention of COVID-19 by traditional Chinese medicine based on the theory of preventive treatment of disease[J]. Journal of Chinese Medicinal Materials, 2021, 44(4): 1021-1030(in Chinese)
    [2] 李煊, 许子贤, 明艳林. 中草药在防治新型冠状病毒肺炎中的应用[J]. 亚热带植物科学, 2020, 49(2): 83-92 Li X, Xu ZX, Ming YL. Application of Chinese herbal medicine in prevention and treatment of coronavirus disease 2019[J]. Subtropical Plant Science, 2020, 49(2): 83-92(in Chinese)
    [3] Osier F, Ting JPY, Fraser J, Lambrecht BN, Romano M, Gazzinelli RT, Bortoluci KR, Zamboni DS, Akbar AN, Evans J, et al. The global response to the COVID-19 pandemic: how have immunology societies contributed?[J]. Nature Reviews Immunology, 2020, 20(10): 594-602
    [4] 崔小平, 崔犇, 杜红心, 张晓松, 张宗娟, 万科, 郎春晖. 新型冠状病毒IgM和IgG抗体检测对新冠肺炎的诊断效能评价[J]. 现代医药卫生, 2020, 36(19): 3015-3017 Cui XP, Cui B, Du HX, Zhang XS, Zhang ZJ, Wan K, Lang CH. Diagnostic performance of IgM and IgG antibody detection in coronavirus disease[J]. Journal of Modern Medicine & Health, 2020, 36(19): 3015-3017(in Chinese)
    [5] 董陈颍, 杨鸿. 新型冠状病毒引起的细胞因子风暴及中医药治疗[J]. 中华中医药学刊, 2020, 38(7): 15-18 Dong CY, Yang H. Cytokine storm by COVID-19 and treatment strategy of traditional Chinese medicine[J]. Chinese Archives of Traditional Chinese Medicine, 2020, 38(7): 15-18(in Chinese)
    [6] 黄苏玥, 沈银忠. 新型冠状病毒疫苗的研发进展[J]. 上海医药, 2021, 42(17): 16-21 Huang SY, Shen YZ. Research and development progress of SARS-CoV-2 vaccines[J]. Shanghai Medical & Pharmaceutical Journal, 2021, 42(17): 16-21(in Chinese)
    [7] 邵菁, 汪长中, 官妍, 吴大强, 王艳, 汪本凡. 新冠疫情下对医学免疫学教学理念的思考[J]. 中国免疫学杂志, 2020, 36(22): 2783-2785, 2790 Shao J, Wang CZ, Guan Y, Wu DQ, Wang Y, Wang BF. Thinking on teaching philosophy in Medical Immunology upon novel coronavirus pandemics[J]. Chinese Journal of Immunology, 2020, 36(22): 2783-2785, 2790(in Chinese)
    [8] 陈大为, 毕京峰, 董漪, 谭钧元, 朱世殊. 中西医结合治疗乙型肝炎策略的重心仍应在调节免疫[J]. 传染病信息, 2011, 24(4): 252-254 Chen DW, Bi JF, Dong Y, Tan JY, Zhu SS. Treatment of hepatitis B using integrated traditional Chinese and western medicine should focus on the regulation of the immune system[J]. Infectious Disease Information, 2011, 24(4): 252-254(in Chinese)
    [9] 张一鸣. 人痘接种术的文献研究[D]. 北京: 中国中医科学院硕士学位论文, 2016 Zhang YM. Literature research on smallpox inoculation[D]. Beijing: Master’s Thesis of China Academy of Chinese Medical Sciences, 2016(in Chinese)
    [10] 王忆勤, 郝一鸣. 从调节免疫力谈中医药防治新型冠状病毒肺炎[J]. 上海中医药杂志, 2020, 54(5): 1-5 Wang YQ, Hao YM. Discussion on prevention and treatment of COVID-19 with traditional Chinese medicine from immunoregulation[J]. Shanghai Journal of Traditional Chinese Medicine, 2020, 54(5): 1-5(in Chinese)
    [11] 耿洪娇, 谢雁鸣. 中医药对新冠病毒肺炎恢复期及出院患者免疫功能调节理论探讨[J]. 世界科学技术-中医药现代化, 2021, 23(2): 482-487 Geng HJ, Xie YM. Discussion on the mechanism of immune function regulation of traditional Chinese medicine in convalescent and discharged patients with new coronavirus pneumonia[J]. Modernization of Traditional Chinese Medicine and Materia Medica-World Science and Technology, 2021, 23(2): 482-487(in Chinese)
    [12] Xu X, Xia J, Zhao SY, Wang Q, Ge GB, Xu F, Liu X, Zhang WD, Yang YL. Qing-Fei-Pai-Du decoction and wogonoside exert anti-inflammatory action through down-regulating USP14 to promote the degradation of activating transcription factor 2[J]. FASEB Journal, 2021, 35(9): e21870
    [13] Qian J, Xu HD, Lü D, Liu W, Chen EG, Zhou Y, Wang Y, Ying KJ, Fan XH. Babaodan controls excessive immune responses and may represent a cytokine-targeted agent suitable for COVID-19 treatment[J]. Biomedicine & Pharmacotherapy, 2021, 139: 111586
    [14] 曹雪涛. 医学免疫学[M]. 北京: 人民卫生出版社, 2018 Cao XT. Medical Immunology[M]. Beijing: People’s Medical Publishing House, 2018
    [15] 单凯, 王美娟, 陈勇, 杨静雯, 陈波, 郭义, 陈泽林. 疫情居家期间预防新型冠状病毒肺炎的中医药适宜技术推荐[J]. 中国民间疗法, 2020, 28(13): 1-3 Shan K, Wang MJ, Chen Y, Yang JW, Chen B, Guo Y, Chen ZL. Recommendation of appropriate technology of traditional Chinese medicine for coronavirus disease 2019 during epidemic outbreak at home[J]. China’s Naturopathy, 2020, 28(13): 1-3(in Chinese)
    [16] Sulaiman I, Chung M, Angel L, Tsay JCJ, Wu BG, Yeung ST, Krolikowski K, Li YH, Duerr R, Schluger R, et al. Microbial signatures in the lower airways of mechanically ventilated COVID-19 patients associated with poor clinical outcome[J]. Nature Microbiology, 2021, 6(10): 1245-1258
    [17] Li XH, Xiang L, Lin Y, Tang Q, Meng FB, Chen W. Computational analysis illustrates the mechanism of QingFei PaiDu decoction in blocking the transition of COVID-19 patients from mild to severe stage[J]. Current Gene Therapy, 2021. DOI: 10.2174/ 1566523221666210907162005
    [18] Wang J, Ge W, Peng X, Yuan LX, He SB, Fu XY. Investigating the active compounds and mechanism of HuaShi XuanFei formula for prevention and treatment of COVID-19 based on network pharmacology and molecular docking analysis[J]. Molecular Diversity, 2021. DOI: 10.1007/S11030-021-10244-0
    [19] 王玥, 杨志国, 王艳华, 李建, 王丹, 李丽维. 黄芪多糖与人参多糖免疫调节作用的研究进展[J]. 食品安全质量检测学报, 2021, 12(3): 891-897 Wang Y, Yang ZG, Wang YH, Li J, Wang D, Li LW. Research progress on immune regulation of Astragalus polysaccharide and Ginseng polysaccharides[J]. Journal of Food Safety & Quality, 2021, 12(3): 891-897(in Chinese)
    [20] 高鑫, 何正有, 罗璞, 蒋用, 毕建军, 汤秀强. 抗新型冠状病毒肺炎(COVID-19)中药复方中高频单味药的研究概述[J]. 国外医药(抗生素分册), 2020, 41(4): 283-289 Gao X, He ZY, Luo P, Jiang Y, Bi JJ, Tang XQ. Research overview of high-frequency single-medicine in Chinese herbal compound against novel coronavirus pneumonia (COVID-19)[J]. World Notes on Antibiotics, 2020, 41(4): 283-289(in Chinese)
    [21] Shi MF, Peng B, Li A, Li ZY, Song P, Li J, Xu RD, Li N. Broad anti-viral capacities of Lian-Hua-Qing-Wen capsule and Jin-Hua-Qing-Gan granule and rational use against COVID-19 based on literature mining[J]. Frontiers in Pharmacology, 2021, 12: 640782
    [22] 王博寒, 史锁芳, 张晓娜. 基于网络药理学的扶土生金康复方调节新型冠状病毒肺炎恢复期免疫功能机制研究[J]. 南京中医药大学学报, 2021, 37(1): 91-95 Wang BH, Shi SF, Zhang XN. Exploration on mechanism of Futu Shengjin rehabilitation formula in regulating immune function during COVID-19 convalescence based on the network pharmacology[J]. Journal of Nanjing University of Traditional Chinese Medicine, 2021, 37(1): 91-95(in Chinese)
    [23] 李俊杰, 李亚玲, 刘永琦, 张志明, 董娟娟, 李高勤, 刘东玲, 靳晓杰, 张利英. M1/M2型肺泡巨噬细胞亚群在新型冠状病毒肺炎中的作用及中医药调控机制研究进展[J]. 中国实验方剂学杂志, 2020, 26(19): 99-107 Li JJ, Li YL, Liu YQ, Zhang ZM, Dong JJ, Li GQ, Liu DL, Jin XJ, Zhang LY. Effect of M1/M2 alveolar macrophage subsets in COVID-19 and regulatory mechanism of traditional Chinese medicine[J]. Chinese Journal of Experimental Traditional Medical Formulae, 2020, 26(19): 99-107(in Chinese)
    [24] Lam CS, Koon HK, Chung VCH, Cheung YT. A public survey of traditional, complementary and integrative medicine use during the COVID-19 outbreak in Hong Kong[J]. PLoS One, 2021, 16(7): e0253890
    [25] 余亚茹, 鲁鹏飞, 王红霞, 黄宝康. 中药防治新型冠状病毒肺炎概述[J]. 药学实践杂志, 2020, 38(3): 202-206, 210 Yu YR, Lu PF, Wang HX, Huang BK. Prevention and treatment of COVID-19 with traditional Chinese medicine[J]. Journal of Pharmaceutical Practice, 2020, 38(3): 202-206, 210(in Chinese)
    [26] 张会择, 杜晓娟, 赖宇. 临“疫”发“微”: 新型冠状病毒肺炎疫情下“病原生物学与医学免疫学”课程思政教学模式的探索与研究[J]. 微生物学通报, 2021, 48(3): 1001-1012 Zhang HZ, Du XJ, Lai Y. Elucidating pathobiology under epidemic: exploration and study on ideological and political education in Pathobiology and Medical Immunology under the COVID-19 epidemic situation[J]. Microbiology China, 2021, 48(3): 1001-1012(in Chinese)
    Related
    Cited by
    Comments
    Comments
    分享到微博
    Submit
Get Citation

MEI Jianjun, CHEN Jianfang. Design and implementation of integrative teaching of traditional Chinese medicine and western medicine in Medical Immunology[J]. Microbiology China, 2022, 49(4): 1375-1385

Copy
Share
Article Metrics
  • Abstract:331
  • PDF: 1483
  • HTML: 693
  • Cited by: 0
History
  • Received:October 18,2021
  • Adopted:November 12,2021
  • Online: March 30,2022
Article QR Code